Related Experiment Video
Updated: Jan 10, 2026

Simultaneous Visualization of the Dynamics of Crosslinked and Single Microtubules In Vitro by TIRF Microscopy
Published on: February 18, 2022
Extended Stability of Ascorbic Acid in Pediatric TPN Admixtures: The Role of Storage Temperature and Emulsion
Rafał Chiczewski1, Żaneta Sobol1, Alicja Pacholska1
1Department of Pharmaceutical Technology, Pomeranian Medical University in Szczecin, Rybacka 1, 70-204 Szczecin, Poland.
Insights
Ascorbic acid (Vitamin C) in pediatric parenteral nutrition is stable refrigerated for 15 days. Room temperature exposure causes vitamin C loss, necessitating improved handling for home TPN programs.
Area of Science:
- Parenteral nutrition
- Nutritional biochemistry
- Pharmaceutical stability
Background:
- Pediatric total parenteral nutrition (TPN) requires stable vitamin formulations.
- Assessing ascorbic acid stability under varied storage conditions is crucial for patient safety.
- Hospital compounding and home administration present different stability challenges.
Purpose of the Study:
- To evaluate the chemical and physical stability of ascorbic acid in pediatric TPN admixtures.
- To compare stability under two distinct storage protocols simulating hospital and home settings.
- To provide data for optimizing pediatric TPN formulation and handling.
Main Methods:
- Quantified ascorbic acid degradation using validated high-performance liquid chromatography (HPLC).
- Assessed physical stability via optical microscopy, dynamic light scattering (DLS), laser diffraction (LD), zeta potential, and pH.
- Examined two storage protocols: 15-day refrigeration followed by 24h room temperature, and 24h supplementation then room temperature storage.
Main Results:
- Ascorbic acid content remained above 90% in both protocols, with degradation increasing with time and temperature.
- Physical stability was maintained; emulsion droplet sizes were <500 nm, with no phase separation.
- Zeta potential confirmed kinetic stability (-20 to -40 mV), and pH remained within safe limits (5.8-6.2).
Conclusions:
- Ascorbic acid is stable in pediatric TPN admixtures refrigerated for up to 15 days.
- A 24-hour room temperature period leads to significant ascorbic acid loss, impacting home TPN.
- Strict cold-chain management and appropriate packaging are vital for maintaining vitamin C integrity in pediatric TPN.
Abstract:
Background/Objectives: This study assessed the chemical and physical stability of ascorbic acid in pediatric total parenteral nutrition (TPN) admixtures under conditions reflecting both hospital compounding and home administration. Methods: Two storage protocols were examined: (A) refrigerated storage (15 days, 4 ± 2 °C) followed by addition of ascorbic acid and a 24-h period of storage at room temperature, and (B) vitamin supplementation within 24 h after composing and storage at 21 ± 2 °C. A validated high-performance liquid chromatography (HPLC) method was used to quantify ascorbic acid degradation. Physical stability was evaluated via optical microscopy, dynamic light scattering (DLS), laser diffraction (LD), zeta potential, and pH measurement. Results: Ascorbic acid content remained above 90% of the declared value in both protocols, although gradual degradation was observed with increasing storage time and temperature. Emulsion droplet sizes remained within pharmacopeial limits (<500 nm), and no coalescence or phase separation was detected. Zeta potential values (-20 to -40 mV) confirmed kinetic stability, while pH ranged from 5.8 to 6.2, remaining within acceptable safety margins. Conclusions: Vitamin C in pediatric TPN admixtures is stable under refrigerated conditions for up to 15 days. However, the additional 24 h at room temperature resulted in measurable loss of ascorbic acid content, suggesting a need for improved guidance in home-based parenteral nutrition, particularly regarding transport and handling. The study underscores the importance of strict cold-chain maintenance and highlights the role of emulsion matrix and packaging in protecting labile vitamins. This research provides practical implications for hospital pharmacists and caregivers, supporting better formulation practices and patient safety in pediatric home TPN programs.
Related Concept Videos
Drug Product Stability
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption
Pharmaceutical Alternatives: Stability-Related Therapeutic Nonequivalence
Polyprotic Acids
Bioavailability Enhancement: Drug Stability Enhancement and GI Retention
Pharmacokinetics in Pediatric Patients: Drug Distribution

